LEGN

Legend Biotech Corporation

60
Fundamentals68/ 100
Valuation50/ 100
Upside potential62/ 100
Risk potential38/ 100

LEGN lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.

LEGN Fundamentals

MetricStatus
Healthy
Stable
Weak
Unavailable

LEGN's revenue is currently healthy, and its profitability is stable, but its cash flow is weak. There isn't enough data to rate its balance sheet.

LEGN PE Valuation

LEGN has no meaningful PE right now: it lost money over the past year.

LEGN Forward outlook

MetricOutlook
--
Strong growth
Strong growth
Strongly improving
Limited
Low

Analysts expect strong earnings and revenue growth for LEGN, with profitability improving. However, they disagree widely on these estimates.

LEGN Risk to reward

ScenarioChangePrice
Upside+62%$30.11
Downside-38%$11.51

Calculated from the latest close: $18.54 on Nov 12.

LEGN's one-year upside scenario is somewhat larger than its downside: +62% against −38%.

LEGN Earnings Per Share

Q3 2023: $-3.01Q4 2023: $-2.96Q1 2024: $-2.44Q2 2024: $-1.40Q3 2024: $-1.74Q4 2024: $-0.87Q1 2025: $-0.98Q2 2025: $-1.22Q3 2025: $-0.65Q4 2025: $-0.89Q1 2026: $-0.92Q2 2026: $-0.40
Q3 2023: $-3.01Q4 2023: $-2.96Q1 2024: $-2.44Q2 2024: $-1.40Q3 2024: $-1.74Q4 2024: $-0.87Q1 2025: $-0.98Q2 2025: $-1.22Q3 2025: $-0.65Q4 2025: $-0.89Q1 2026: $-0.92Q2 2026: $-0.40
QuarterTTM EPSYoY
Q2 2026-$0.40+$0.82
Q1 2026-$0.92+$0.06
Q4 2025-$0.89-$0.02
Q3 2025-$0.65+$1.09
Q2 2025-$1.22+$0.18
Q1 2025-$0.98+$1.46
Q4 2024-$0.87+$2.09
Q3 2024-$1.74+$1.27

LEGN is still losing money, but far less than before: $0.40 per share over the past year, against $3.32 at its worst in early 2023.

LEGN Quarterly Revenue

Q3 2023: $96MQ4 2023: $79MQ1 2024: $94MQ2 2024: $187MQ3 2024: $160MQ4 2024: $187MQ1 2025: $195MQ2 2025: $255MQ3 2025: $272MQ4 2025: $306MQ1 2026: $305MQ2 2026: $388M
Q3 2023: $96MQ4 2023: $79MQ1 2024: $94MQ2 2024: $187MQ3 2024: $160MQ4 2024: $187MQ1 2025: $195MQ2 2025: $255MQ3 2025: $272MQ4 2025: $306MQ1 2026: $305MQ2 2026: $388M
QuarterRevenueYoY
Q2 2026$387.5M+52%
Q1 2026$305.1M+56%
Q4 2025$306.4M+64%
Q3 2025$272.3M+70%
Q2 2025$255.1M+37%
Q1 2025$195.1M+108%
Q4 2024$186.5M+135%
Q3 2024$160.2M+67%

LEGN's revenue has grown year over year for 13 quarters in a row: $388M last quarter, up 52% from the same quarter a year ago.

LEGN Free Cash Flow

Q3 2023: −$66MQ4 2023: −$102MQ1 2024: $9MQ2 2024: −$5MQ3 2024: −$78MQ4 2024: −$84MQ1 2025: −$106MQ2 2025: −$22MQ3 2025: $24MQ4 2025: −$127MQ1 2026: −$111MQ2 2026: −$41M
Q3 2023: −$66MQ4 2023: −$102MQ1 2024: $9MQ2 2024: −$5MQ3 2024: −$78MQ4 2024: −$84MQ1 2025: −$106MQ2 2025: −$22MQ3 2025: $24MQ4 2025: −$127MQ1 2026: −$111MQ2 2026: −$41M
QuarterFree cash flowYoY
Q2 2026-$41.5M-$19.2M
Q1 2026-$111.3M-$5.6M
Q4 2025-$126.6M-$42.1M
Q3 2025$23.8M+$101.7M
Q2 2025-$22.3M-$17.2M
Q1 2025-$105.8M-1240%
Q4 2024-$84.5M+$18M
Q3 2024-$77.9M-$11.6M

LEGN has burned cash in almost every quarter: −$256M over the past year, against −$290M the year before.

LEGN Total Shares

Q3 2023: 182MQ4 2023: 182MQ1 2024: 364MQ2 2024: 183MQ3 2024: 183MQ4 2024: 366MQ1 2025: 368MQ2 2025: 368MQ3 2025: 369MQ4 2025: 185MQ1 2026: 185MQ2 2026: 194M
Q3 2023: 182MQ4 2023: 182MQ1 2024: 364MQ2 2024: 183MQ3 2024: 183MQ4 2024: 366MQ1 2025: 368MQ2 2025: 368MQ3 2025: 369MQ4 2025: 185MQ1 2026: 185MQ2 2026: 194M
PeriodChange %Net change
Quarterly+4.9%+9.1M shares
1 year-47%-174M shares
3 years+11%+18.5M shares
5 years+40%+55.3M shares
Available history+93%+93.6M shares

LEGN has 194M diluted shares, down 47% from a year ago.

LEGN Net Leverage

LEGN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

LEGN Weekly Momentum

MetricValueStatus
RSI43.8Neutral
Stochastic63.0Neutral

LEGN's weekly RSI is 44 (neutral) and its Stochastic is 63 (neutral).

LEGN PE vs Healthcare Sector

LEGN has no meaningful PE right now: it lost money over the past year.

LEGN Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$19.75.9% below
20 week MA$20.911% below
50 week MA$22.116% below
100 week MA$28.234% below
200 week MA$42.356% below

LEGN is in a downtrend: it's below all five of its weekly moving averages, and 56% below its 200-week average.

LEGN Yearly ROI

YearStart priceEnd priceROI
2020$37.0$29.5-20%
2021$29.5$48.7+65%
2022$48.7$49.8+2.3%
2023$49.8$60.2+21%
2024$60.2$32.5-46%
2025$32.5$22.5-31%
2026 YTD$22.5$18.5-18%

LEGN has finished lower in three of the last six years. It's down 18% so far in 2026.

Give your agent the market.

Get API key